CODX
Co-Diagnostics, Inc.
There isn't enough reported data to score CODX yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
CODX Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Under pressure | |
| Strong |
CODX's revenue and balance sheet are currently healthy, but its profitability and cash flow are under pressure.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
CODX PE Valuation
CODX has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
CODX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| High |
Analysts expect CODX's losses to shrink, with revenue growing.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
CODX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$22.88 | +$6.82 |
| Q2 2026 | -$26.67 | +$7.83 |
| Q1 2026 | -$32.11 | +$2.99 |
| Q4 2025 | -$35.25 | +$1.95 |
| Q3 2025 | -$29.70 | +$11.40 |
| Q2 2025 | -$34.50 | +$3.00 |
| Q1 2025 | -$35.10 | +$4.20 |
| Q4 2024 | -$37.20 | -$1.20 |
CODX is still losing money, but less than at its worst: $22.88 per share over the past year, against $41.40 at its worst in late 2023.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over CODX on earnings quality, reporting a profit while its opponent remains loss making.
CODX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $282.9K | +95% |
| Q2 2026 | $166.1K | +2% |
| Q1 2026 | $146K | +190% |
| Q4 2025 | $263.9K | +77% |
| Q3 2025 | $145.4K | -77% |
| Q2 2025 | $162.9K | -94% |
| Q1 2025 | $50.3K | -89% |
| Q4 2024 | $149.3K | -96% |
CODX's revenue is recovering but still below its 2021 peak: $282,881 last quarter, up 95% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -2216% | +2608 points |
| Q2 2026 | -3732% | +1214 points |
| Q1 2026 | -6309% | +10701 points |
| Q4 2025 | -10057% | -2083 points |
| Q3 2025 | -4824% | -3228 points |
| Q2 2025 | -4946% | -4657 points |
| Q1 2025 | -17010% | -14817 points |
| Q4 2024 | -7974% | -7641 points |
CODX's operating margin was −2216% last quarter, up 2608 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over CODX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over CODX on profitability, with a higher operating margin.
CODX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$5.7M | +$280.7K |
| Q2 2026 | -$7.2M | +$1.5M |
| Q1 2026 | -$8M | +$848.8K |
| Q4 2025 | -$6.3M | +$2M |
| Q3 2025 | -$6M | +$1.4M |
| Q2 2025 | -$8.7M | -$3.4M |
| Q1 2025 | -$8.8M | +$55.5K |
| Q4 2024 | -$8.3M | -$3.1M |
CODX has burned cash in most quarters: −$27M over the past year, against −$32M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over CODX on cash generation, producing positive trailing cash flow while its opponent burns cash.
CODX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +46% | +2M shares |
| 1 year | +468% | +5.2M shares |
| 3 years | +547% | +5.3M shares |
| 5 years | +533% | +5.3M shares |
| Available history | +725% | +5.5M shares |
CODX has 6M diluted shares, up 468% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | $159,673 |
| Q3 2023 | $166,326 |
| Q2 2023 | $555,734 |
| Q1 2023 | $482,196 |
| Q4 2022 | $1.2M |
| Q3 2022 | $10.4M |
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over CODX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
CODX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2022 | -7.7x | Net Cash |
| Q2 2022 | -2.8x | Net Cash |
| Q1 2022 | -2.1x | Net Cash |
| Q4 2021 | -1.9x | Net Cash |
| Q3 2021 | -1.6x | Net Cash |
| Q2 2021 | -1.4x | Net Cash |
| Q1 2021 | -1.1x | Net Cash |
| Q4 2020 | -1.0x | Net Cash |
CODX has more cash than debt.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
CODX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.5 | Neutral |
| Stochastic | 0.9 | Oversold |
CODX's weekly RSI is 34 (neutral) and its Stochastic is 1 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
CODX PE vs Healthcare Sector
| Metric | CODX | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
CODX has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
CODX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.67 | 60% below |
| 20 week MA | $1.28 | 79% below |
| 50 week MA | $2.84 | 90% below |
| 100 week MA | $7.77 | 97% below |
| 200 week MA | $24.5 | 99% below |
CODX is in a downtrend: it's below all five of its weekly moving averages, and 99% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over CODX on trend strength, trading above more of its moving averages.
CODX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $27.8 | $325.2 | +1069% |
| 2021 | $325.2 | $282.3 | -13% |
| 2022 | $282.3 | $76.5 | -73% |
| 2023 | $76.5 | $39.9 | -48% |
| 2024 | $39.9 | $21.9 | -45% |
| 2025 | $21.9 | $7.05 | -68% |
| 2026 YTD | $7.05 | $0.27 | -96% |
CODX has finished five years in a row lower, and it's down 96% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over CODX on returns for 2026, with the stronger performance.